Sign in
4

Changes in Ownership

Serina Therapeutics, Inc. Filed Acc 0001708599-25-000038

Options or other derivatives

  • Director acquired 96,525 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Venkatesan Jay Director 2025-04-08 Grant or award · Series A Convertible Preferred Stock +96,525 $5.18 $500,000 96,525 I: show line 1 in the form
Loading xslF345X05/wk-form4_1744315385.xml…